Advisory Services Network’s TherapeuticsMD TXMD Stock Holding History

Advisory Services Network’s Portfolio TXMD Stock Details TXMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-4	Closed	-$8	–	4458
2026 Q1	$8	Buy	+4	New	+$9	﹤0.01%	4817
2025 Q4	–	Sell	-14	Closed	-$15	–	4091
2025 Q3	$15	Buy	+14	New	+$16	﹤0.01%	4498
2021 Q1	–	Sell	-10	Closed	-$1K	–	2829
2020 Q4	$1K	Hold	10	–	–	﹤0.01%	3200
2020 Q3	$1K	Buy	+10	New	+$797	﹤0.01%	3415
2020 Q2	–	Sell	-10	Closed	-$1K	–	2623
2020 Q1	$1K	Hold	10	–	–	﹤0.01%	2945
2019 Q4	$1K	Hold	10	–	–	﹤0.01%	3015
2019 Q3	$1K	Hold	10	–	–	﹤0.01%	2753
2019 Q2	$1K	Buy	+10	New	+$1.79K	﹤0.01%	2751
2018 Q2	–	Sell	-20	Closed	-$5K	–	2693
2018 Q1	$5K	Buy	+20	New	+$5.61K	﹤0.01%	2137
2017 Q2	–	Sell	-3	Closed	-$1K	–	2377
2017 Q1	$1K	Buy	+3	New	+$928	﹤0.01%	2132

Other funds holding TXMD

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Clearline Capital New York $1.68B AUM 53.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Tejara Capital London, United Kingdom $243M AUM 9.84% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Advisory Services Network's TXMD Position: Q2 2026 in Review

Advisory Services Network sold out of TherapeuticsMD (TXMD) in Q2 2026, closing a stake of 4 shares — an estimated $8 sold.

Advisory Services Network first reported a position in TXMD in Q1 2017 and held it in 10 quarters. The position peaked at $5K in Q1 2018. 44 funds tracked by Wall St. Rank hold TXMD as of Q2 2026.

Advisory Services Network reported no remaining TherapeuticsMD position as of Q2 2026 after selling out during the quarter.
Advisory Services Network sold 4 TherapeuticsMD shares in Q2 2026, an estimated $8.
Advisory Services Network first reported a position in TherapeuticsMD in Q1 2017 and held it in 10 quarters.
Advisory Services Network's TherapeuticsMD position peaked at $5K in Q1 2018.
44 funds tracked by Wall St. Rank held TherapeuticsMD as of Q2 2026.

Based on Advisory Services Network's 13F filing for Q2 2026, filed 12 Aug 2026.